鴻傑藥品有限公司

主成分
Nimesulide contains not less than 98.5% and not more than 101.5% of C13H12N2O5S, calculated on the dried substances. 
適應症
消炎鎮痛藥
主成分
Betahistine Dihydrochloride (betahistine hydrochloride) contains not less than 99.0% and not more than 101.0% of C8H12H2‧2HCl, calculated on the dried basis. 
適應症
治療梅尼艾氏症候群所引起之眩暈、聽力障礙。
主成分
Levodopa contains not less than 99.0% and not more than 101.0% of C9H11NO4, calculated on the dried substance. 
適應症
帕金森症治療藥
主成分
Enalapril Maleate contains not less than 98.0% and not more than 102.0% of C20H28N2O5‧C4H4O4 calculated on the dried basis. 
適應症
降血壓劑
主成分
Levofloxacin contains not less than 98.5%~102.0% of C18H20FN3O4 calculated on the anhydrous basis. 
適應症
抗生素。
主成分
Azithromycin contains not less than 96.0% and not more than 102.0% of C38H72N2O12‧2H2O calculated on the anhydrous substance. 
適應症
抗生素
主成分
Gliclazide contains not less than 99.0% and not more than 101.0% of C15H21N3O3S, calculated on the dried substance. 
適應症
降血糖劑。
主成分
Anethol Trithione contains not less than 98.0% of C10H8OS3 calculated on the dried basis. 
適應症
利膽劑。
主成分
Piracetam contains not less than 98.0% and not more than 102.0% of C6H10N2O2 calculated on the dried substance. 
適應症
血管擴張劑。
主成分
Pregabalin contains not less than 98.0% and not more than 102.0% of C8H17NO2, calculated on the anhydrous basis. 
適應症
治療癲癇用藥
主成分
Tadalafil contains not less than 97.5% and not more than 102.0% of C22H19N3O4, calculated on the anhydrous basis. 
適應症
治療勃起功能障礙
主成分
Carbidopa contains not less than 98.5% and not more than 101.0% of C10H14N2O4‧H2O, calculated on the dried substance. 
適應症
帕金森氏症治療藥
主成分
Rivaroxaban (modification-I) contains not less than 98.5% and not more than 101.5% of C19H18ClN3O5S, calculated on the anhydrous basis. 
適應症
抗凝血劑
主成分
Doxazosin mesilate contains not less than 98.0% and not more than 102.0% of C24H29N5O8S, calculated on the anhydrous substance. 
適應症
血管擴張劑
主成分
Calcium Polystyrene Sulfonate (eq. to Calcium polystyrene sulphonate), C8H7CaO3S+, is a cation-exchange resin prepared in the calcium form containing not less than 6.5% w/w and not more than 9.5% w/w of calcium, calculated with reference to the dried substance. Each g exchanges not less than 1.3 mEq and not more than 2.0mEq of potassium, calculated with reference to the dried substance. 
適應症
急性及慢性腎不全伴隨之高血鉀症
主成分
Valsartan contains not less than 99.0% and not more than 101.0% of C24H29N5O3, calculated on the anhydrous basis. 
適應症
降血壓劑
主成分
Sugammadex sodium contains not less than 93.0% and not more than 102.0% of C72H104O48S8Na8, calculated on the anhydrous and solvent free basis. 
適應症
拮抗rocuronium或vecuronium誘導的神經肌肉阻斷
主成分
Sitagliptin Phosphate Monohydrate contains not less than 98.0% and not more than 102.0% of C16H15F6N5O‧H3PO4 on the anhydrous basis. 
適應症
降血糖藥
主成分
Peramivir Hydrate contains not less than 98.0% and not more than 102.0% of C15H28N4O4, calculated on the anhydrous basis. 
適應症
抗病毒藥
主成分
Sucralfate contains: - sucrose octasulfate (C12H14O35S88-):30.0% to 36.0% - aluminium (Al):16.5% to 18.5% 
適應症
消化性潰瘍用藥
主成分
Varenicline Tartrate contains not less than 98.0% and not more than 102.0% of C13H13N3‧C4H6O6, calculated on the anhydrous basis 
適應症
戒菸輔助劑
主成分
Pirfenidone contains not less than 98.0% and not more than 102.0% of C12H11NO, calculated on the anhydrous basis. 
適應症
治療特發性肺纖維化用藥
主成分
Parecoxib sodium contains not less than 98.0% and not more than 102.0% of C19H17N2O4SNa, calculated on the anhydrous basis. 
適應症
使用於外科手術後疼痛之緩解
主成分
Quetiapine Fumarate contains not less than 99.0% and not more than 101.0% of C46H54N6O8S2, calculated on the anhydrous basis. 
適應症
抗思覺失調症、雙極性疾患之躁症用藥
主成分
Perindopril Erbumine contains not less than 99.0% and not more than 101.0% of C19H32N2O5‧C4H11N calculated on the dried basis. 
適應症
降血壓劑。
主成分
Entacapone contains not less than 98.0% and not more than 102.0% of C14H15N3O5 calculated on the dried basis. 
適應症
抗帕金森氏症劑
主成分
Benazepril HCl contains not less than 98.0% and not more than 102.0% of C24H28N2O5˙HCl calculated on the dried basis. 
適應症
血管收縮素轉化每抑制劑
主成分
Amisulpride contains not less than 99.0% and not more than 101.0% of C17H27N3O4S, calculated on the dried substance. 
適應症
抗精神病。
主成分
Rivastigmine Hydrogen Tartrate contains not less than 98.0% and not more than 102.0% of C14H22N2O2˙C4H6O6 calculated on the dried basis. 
適應症
輕度至中度阿滋海默氏病之失智症。
主成分
Atorvastatin Calcium (Amorphous) contains not less than 98.0% and not more than 102.0% of C66H68CaF2N4O10 calculated on the dried basis. 
適應症
降血脂藥。
主成分
Antimony Potassium Tartrate contains not less than 99.0% and not more than 103.0% of C8H4K2O12SB2・3H2O, calculated on the anhydrous basis. 
適應症
催吐藥、抗血吸蟲藥